[
    [
        {
            "time": "",
            "original_text": "[买 入 评 级] 医 药 生 物 行 业 投 资 策 略 ： 进 口 抗 癌 药 关 税 政 策 无 需 过 度 放 大 依 然 看 好 国 内 创 新 药 企 业",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "进口抗癌药",
                    "关税政策",
                    "国内创新药企业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]